Beximco Pharma approves 12.50pc cash dividend

Beximco Pharmaceuticals Ltd approved 12.50 per cent cash dividend for the year ended on June 30, 2017.
The approval came at its 41st Annual General Meeting (AGM) held at Beximco Industrial Park, Kashimpur in Gazipur on Saturday, according to a statement.
The meeting was presided over by Salman F Rahman, Vice-Chairman of the company. Nazmul Hassan, Managing Director, Iqbal Ahmed, Director, OK Chowdhury, Director, AB Siddiqur Rahman, Director, Dr Abdur Rahman Khan and Shah Monjurul Hoque, Independent Directors, Barrister Rafique-ul Huq, Legal Advisor, Ali Nawaz, Chief Financial Officer, and Mohammad Asad Ullah, Executive Director and Company Secretary, attended the meeting.
The company sold medicine and healthcare instruments worth Tk 15,508.78 million and earned a gross and net profit of Tk 7,184.88 million and Tk 2,226.70 million respectively for the year ended 30 June, 2017.
The AGM approved the Audited Financial Statements for the year ended on June 30, 2017, appointment of directors as well as independent directors and auditors for the year 2017-18.